Mucositis is a major oncological problem. The entire gastrointestinal and genitourinary tract and also other mucosal surfaces can be affected in recipients of radiotherapy, and/or chemotherapy. Major progress has been made in recent years in understanding the mechanisms of oral and small intestinal mucositis, which appears to be more prominent than colonic damage. This progress is largely due to the development of representative laboratory animal models of mucositis. This review focuses on the development and establishment of the Dark Agouti rat mammary adenocarcinoma model by the Mucositis Research Group of the University of Adelaide over the past 20 years to characterize the mechanisms underlying methotrexate-, 5-fluorouracil-, and irinotecan-induced mucositis. It also aims to summarize the results from studies using different animal model systems to identify new molecular and cellular markers of mucositis.
KeefeDMKBrealeyJGolandGJCumminsAG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut2000; 47: 632–7.
2.
GibsonRJKeefeDMKThompsonFMClarkeJMGolandGJCumminsAG. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci2002; 47: 2751–7.
3.
SonisSTComplications of cancer and their treatment: oral complications. In: HollandJFFreiEBastRCKufeDWMortonDLWeichselbaumRR (eds). Cancer medicine, 3 ed. London: Lea & Febiger, 1993, pp. 2381–8.
4.
KeefeDMSchubertMMEltingLSSonisSTEpsteinJBRaber-DurlacherJEMiglioratiCAMcGuireDBHutchinsRDPetersonDE. Mucositis Study Section M. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer2007; 109: 820–31.
5.
IkunoNSodaHWatanabeMOkaM. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. J Natl Cancer Inst1995; 87: 1876–83.
6.
TakasunaKHagiwaraTHirohashiMKatoMNomuraMNagaiEYokoiTKamatakiT. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer Res1996; 56: 3752–7.
7.
PottenCSWilsonJWBoothC. Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells1997; 15: 82–93.
8.
PearsonADJCraftAWPledgerJVEasthamEJLakerMFPearsonGL. Small bowel function in acute lymphoblastic leukemia. Arch Dis Child1984; 59: 460–5.
9.
CraftAWRankinAAherneW. Methotrexate absorption in children with acute lymphoblastic leukemia. Cancer Treatment Rep1981; 65: 77–81.
10.
DeitchEA. Bacterial translocation: the influence of dietary variables. Gut1994; 35: S23–7.
11.
ParkinsCSFowlerJFYuS. A murine model of lip epidermal/mucosal reactions to X-irradiation. Radiother Oncol1983; 1: 159–65.
12.
XuF-Xvan der SchuerenEKian AngK. Acute reactions of the lip mucosa of mice to fractionated irradiations. Radiother Oncol1984; 1: 369–74.
13.
MosesRKummermehrJ. Radiation response of the mouse tongue epithelium. Br J Cancer1986; 53: 12–15.
14.
SonisSTTraceyCShklarGJensonJFlorineD. An animal model for mucositis induced by cancer chemotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod1990; 69: 437–43.
15.
RobinsonBAClutterbuckRDMillarJLMcElwainTJ. Epidermal growth factor (hEGF) has no effect on murine intestine epithelial damage and regeneration after melphalan. Br J Cancer1985; 52: 733–7.
16.
CastellinoSElionGBGriffithOWDewhirstMKurtzbergJCattleyRCScottPBignerDDFriedmanHS. Development of a model of melphalan-induced gastrointestinal toxicity in mice. Cancer Chemother Pharmacol1993; 31: 376–80.
17.
ThakkarNSPottenCS. Abrogation of adriamycin toxicity in vivo by cycloheximide. Biochem Pharmacol1992; 43: 1683–91.
18.
AnilkumarTVSarrafCEHuntTAlisonMR. The nature of cytotoxic drug-induced cell death in murine intestinal crypts. Br J Cancer1992; 65: 552–8.
HuangFSKempCJWilliamsJLErwinCRWarnerBW. Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury. Am J Physiol-Gastrointest Liver Physiol2002; 282: G432–42.
21.
Carneiro-FilhoBAOriaRBReaKWBritoGACFujiiJObrigTLimaAAMGuerrantRL. Alanyl-glutambie hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice. Nutrition2004; 20: 934–41.
22.
de KoningBAEvan DierenJMLindenbergh-KortleveDJvan der SluisMMatsumotoTYamaguchiKEinerhandAWSamsomJNPietersRNieuwenhuisEES. Contributions of mucosal immune cells to methotrexate-induced mucositis. Int Immunol2006; 18: 941–9.
23.
BowenJM. Development of the rat model of lapatinib-induced diarrhoea. Scientifica2014; 2014: 194185–194185.
24.
KeefeDMK. Gastrointestinal mucositis: a new biological model. Support Care Cancer2004; 12: 6–9.
25.
GibsonRJBowenJMInglisMRBCumminsAGKeefeDMK. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol2003; 18: 1095–100.
26.
BowenJMGibsonRJCumminsAGTyskinAKeefeDMK. Irinotecan changes gene expression in the small intestine of the rat with breast cancer. Cancer Chemother Pharmacol2007; 59: 337–48.
27.
BowenJMGibsonRJKeefeDMCumminsAG. Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans. Pathology2005; 37: 56–62.
28.
GibsonRJKeefeDMKClarkeJMRegesterGOThompsonFMGolandGJEdwardsBGCumminsAG. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother Pharmacol2002; 50: 53–8.
29.
GibsonRJBowenJMAlvarezEFinnieJKeefeDMK. Establishment of a single-dose irinotecan model of gastrointestinal mucositis. Chemotherapy2007; 53: 360–9.
30.
RofeAMBourgeoisCSWashingtonJMPhilcoxJCCoyleP. Metabolic consequences of methotrexate therapy in tumor-bearing rats. Immunol Cell Biol1994; 72: 43–8.
31.
TomasFMChandlerCSCoylePBourgeoisCSBurgoyneJLRofeAM. Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats. Biochem J1994; 301: 769–75.
RajagopalanPTRZhangZQMcCourtLDwyerMBenkovicSJHammesGG. Interaction of dihydrofolate reductase with methotrexate: Ensemble and single-molecule kinetics. Proc Natl Acad Sci U S A2002; 99: 13481–6.
34.
RussellDH. Effects of methotrexate and cytosine-arabinoside on polyamine metabolism in a mouse L1210 leukemia. Cancer Res1972; 32: 2459–62.
35.
FarberSDiamondLKMercerRDSylvesterRFJrWolffJA. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). New Engl J Med1948; 238: 787–93.
36.
ValerinoDMJohnsDZaharkoDOliverioV. Studies of the metabolism of methotrexate by intestinal flora—I: Identification and study of biological properties of the metabolite 4-amino-4-deoxy-N10-methylpteroic acid. Biochem Pharmacol1972; 21: 821–31.
37.
GibsonRJBowenJMCumminsAGKeefeDMK. Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the rat. Clin Exper Med2005; 4: 188–95.
38.
LoganRStringerABowenJGibsonRSonisSKeefeD. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?Cancer Chemother Pharmacol2009; 63: 239–51.
39.
RenesIBVerburgMBulsingNPFerdinandusseSBullerHADekkerJEinerhandAWC. Protection of the Peyer's patch-associated crypt and villus epithelium against methotrexate-induced damage is based on its distinct regulation of proliferation. J Pathol2002; 198: 60–8.
40.
BilimVKawasakiTTakahashiKTomitaY. Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes. J Exp Clin Cancer Res2000; 19: 483–8.
41.
VerburgMRenesIBMeijerHPTaminiauJBullerHAEinerhandAWCDekkerJ. Selective sparing of goblet cells and Paneth cells in the intestine of methotrexate-treated rats. Am J Physiol-Gastrointest Liver Physiol2000; 279: G1037–47.
42.
HamadaKShitaraYSekineSHorieT. Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats. Cancer Chemother Pharmacol2010; 66: 1031–8.
43.
Van ItallieCMAndersonJM. Claudins and epithelial paracellular transport. Ann Rev Physiol2006; 68: 403–29.
44.
GowAJDuranDMalcolmSIschiropoulosH. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett1996; 385: 63–6.
45.
MiyazonoYGaoFHorieT. Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats. Scand J Gastroenterol2004; 39: 1119–27.
46.
GaoFHorieT. A synthetic analog of prostaglandin E-1 prevents the production of reactive oxygen species in the intestinal mucosa of methotrexate-treated rats. Life Sci2002; 71: 1091–9.
47.
RaoRKBasuroySRaoVUKarnakyKJGuptaA. Tyrosine phosphorylation and dissociation of occludin-Z0-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J2002; 368: 471–81.
48.
Di MarzoVIzzoAA. Endocannabinoid overactivity and intestinal inflammation. Gut2006; 55: 1373–6.
49.
D'ArgenioGPetrosinoSGianfraniCValentiMScaglioneGGrandoneINigamSSorrentiniIMazzarellaGDi MarzoV. Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. J Mol Med2007; 85: 523–30.
50.
BergRDBacterial translocation from the gastrointestinal tract. In: PaulPSFrancisDH (eds). Mechanisms in the pathogenesis of enteric diseases 2. Advances in experimental medicine and biology, New York: Kluwer Academic/Plenum Publications, 1999, pp. 11–30..
51.
Sandovsky-LosicaHSegalE. Interaction of Candida albicans with murine gastrointestinal mucosa: effect of irradiation on adherence in vitro. Med Mycol1989; 27: 345–52.
52.
RingsEKrasinskiSDVanbeersEHMoormanAFMDekkerJMontgomeryRKGrandRJBullerHA. Restriction of lactase gene expression along the proximal-to-distal axis of rat small intestine occurs during postnatal development. Gastroenterology1994; 106: 1223–32.
53.
AbreuMT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol2010; 10: 131–43.
TaupinDRPangKCGreenSPGiraudAS. The trefoil peptides spasmolytic polypeptide and intestinal trefoil factor are major secretory products of the rat gut. Peptides1995; 16: 1001–5.
56.
PritchardDMPrintCO'ReillyLAdamsJMPottenCSHickmanJA. Bcl-w is an important determinant of damage-induced apoptosis in epithelia of small and large intestine. Oncogene2000; 19: 3955–9.
57.
TaminiauJGallDGHamiltonJR. Response of the rat small-intestine epithelium to methotrexate. Gut1980; 21: 486–92.
58.
HamadaKKakigawaNSekineSShitaraYHorieT. Disruption of ZO-1/claudin-4 interaction in relation to inflammatory responses in methotrexate-induced intestinal mucositis. Cancer Chemother Pharmacol2013; 72: 757–65.
59.
MaedaTMiyazonoYItoKHamadaKSekineSHorieT. Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats. Cancer Chemother Pharmacol2010; 65: 1117–23.
60.
ShethPBasuroySLiCYNarenAPRaoRK. Role of phosphatidylinositol 3-kinase in oxidative stress-induced disruption of tight junctions. J Biol Chem2003; 278: 49239–45.
61.
KolliVKAbrahamPRabiS. Methotrexate-induced nitrosative stress may play a critical role in small intestinal damage in the rat. Arch Toxicol2008; 82: 763–70.
62.
LeitãoRFBritoGAOriáRBBraga-NetoMBBellaguardaEASilvaJVGomesASLima-JúniorRCSiqueiraFJFreireRS. Role of inducible nitric oxide synthase pathway on methotrexate-induced intestinal mucositis in rodents. BMC Gastroenterol2011; 11: 90–90.
63.
HornbyPJProutySM. Involvement of cannabinoid receptors in gut motility and visceral perception. Br J Pharmacol2004; 141: 1335–45.
64.
HirotaniYYamamotoKIkedaKArakawaYLiJKitamuraKKurokawaNTanakaeK. Correlation between plasma glucagon-like peptide 2 levels and proliferative makers in small intestinal injury in rats induced by methotrexate administration. Biol Pharm Bull2006; 29: 2327–30.
65.
BergRDGarlingtonAW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun1979; 23: 403–11.
66.
SongDSShiBXueHLiYSYuBJXuZLiuFKLiJS. Green fluorescent protein labeling Escherichia coli TG1 confirms intestinal bacterial translocation in a rat model of chemotherapy. Curr Microbiol2006; 52: 69–73.
67.
de KoningBAELindenbergh-KortleveDJPietersRRingsEBullerHARenesIBEinerhandAWC. The effect of cytostatic drug treatment on intestine-specific transcription factors Cdx2, GATA-4 and HNF-1 alpha in mice. Cancer Chemother Pharmacol2006; 57: 801–10.
68.
BoudreauFRingsEvan WeringHMKimRKSwainGPKrasinskiSDMoffettJGrandRJSuhERTraberPG. Hepatocyte nuclear factor-1 alpha, GATA-4, and caudal related homeodomain protein Cdx2 interact functionally to modulate intestinal gene transcription – Implication for the developmental regulation of the sucrose-isomaltase gene. J Biol Chem2002; 277: 31909–17.
69.
ClatworthyJPSubramanianV. Stem cells and the regulation of proliferation, differentiation and patterning in the intestinal epithelium: emerging insights from gene expression patterns, transgenic and gene ablation studies. Mech Dev2001; 101: 3–9.
VerburgMRenesIBVan NispenDFerdinandusseSJorritsmaMBullerHAEinerhandAWCDekkerJ. Specific responses in rat small intestinal epithelial mRNA expression and protein levels during chemotherapeutic damage and regeneration. J Histochem Cytochem2002; 50: 1525–36.
72.
BabyatskyMWdeBeaumontMThimLPodolskyDK. Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology1996; 110: 489–97.
73.
ChineryRPlayfordRJ. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin Sci1995; 88: 401–3.
74.
CookGAThimLYeomansNDGiraudAS. Oral human spasmolytic polypeptide protects against aspirin-induced gastric injury in rats. J Gastroenterol Hepatol1998; 13: 363–70.
75.
KindonHPothoulakisCThimLLynchdevaneyGPodolskyDK. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology1995; 109: 516–23.
76.
JeffreyGPOatesPSWangTCBabyatskyMWBrandSJ. Spasmolytic polypetide - a trefoil peptide secreted by rat gastric mucous cells. Gastroenterology1994; 106: 336–45.
77.
SuemoriSLynchdevaneyKPodolskyDK. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A1991; 88: 11017–21.
78.
XianCJHowarthGSMardellCECoolJCFamilariMReadLCGiraudAS. Temporal changes in TFF3 expression and jejunal morphology during methotrexate-induced damage and repair. Am J Physiol-Gastrointest Liver Physiol1999; 277: G785–95.
79.
Schmassmann A, Hirschi C, Stettler C, Poulsom R, Halter F. Recent work with hepatocyte growth scatter factor. In: Halter F, Winton D, Wright NA (eds). The gut as a model in cell and molecular biology. Dordrecht: Springer, 1997, pp.180–93.
80.
KatoYYuDHSchwartzMZ. Enhancement of intestinal adaptation by hepatocyte growth factor. J Pediatr Surg1998; 33: 235–9.
81.
KinoshitaYKishiKAsaharaMMatsushimaYWangHYMiyazawaKKitamuraNChibaT. Production and activation of hepatocyte growth factor during the healing of rat gastric ulcers. Digestion1997; 58: 225–31.
82.
GokeMKanaiMPodolskyDK. Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am J Physiol-Gastrointest Liver Physiol1998; 274: G809–18.
83.
XianCJCouperRHowarthGSReadLCKallincosNC. Increased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositis. Br J Cancer2000; 82: 945–52.
84.
PetersGJBackusHHJFreemantleSvan TriestBCodacci-PisanelliGvan der WiltCLSmidKLunecJCalvertAHMarshSMcLeodHLBloemenaEMeijerSJansenGvan GroeningenCJPinedoHM. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta-Mol Basis Dis2002; 1587: 194–205.
85.
ElsteinKHMoleMLSetzerRWZuckerRMKavlockRJRogersJMLauC. Nucleoside-mediated mitigation of 5-fluorouracil-induced toxicity in synchronized murine erythroleukemic cells. Toxicol Appl Pharmacol1997; 146: 29–39.
86.
GhoshalKJacobST. An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug. Biochem Pharmacol1997; 53: 1569–75.
87.
WadlerSHorowitzRZhangHYSchwartzEL. Effects of perturbations of pools of deoxyribonucleoside triphosphates on expression of ribonucleotide reductase, a G(1)/S transition state enzyme, in p53-mutated cells. Biochem Pharmacol1998; 55: 1353–60.
88.
TakedaHHaisaMNaomotoYKawashimaRSatomotoKYamatujiTTanakaN. Effect of 5-fluorouracil on cell cycle regulatory proteins in human colon cancer cell line. Jpn J Cancer Res1999; 90: 677–84.
89.
InadaTIchikawaAKubotaTOgataYMoossaAHoffmanRM. 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice. Anticancer Res1997; 17: 1965–71.
90.
ChangCTHoTYLinHLiangJAHuangHCLiCCLoHYWuSLHuangYFHsiangCY. 5-Fluorouracil induced intestinal mucositis via nuclear factor-kappa B activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS One2012; 7: 8–8.
91.
StringerAMGibsonRJLoganRMBowenJMYeohASJHamiltonJKeefeDMK. Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis. Exp Biol Med2009; 234: 430–41.
92.
SimonGLGorbachSL. Intestinal flora in health and disease. Gastroenterology1984; 86: 174–93.
93.
SimonGLGorbachSL. The human intestinal microflora. Dig Dis Sci1986; 31: S147–62.
94.
SadoffL. Overwhelming 5-fluorouracil toxicity in patients whose diabetes is poorly controlled. Am J Clin Oncol-Cancer Clin Trial1998; 21: 605–7.
95.
MaoJKimBMRajurkarMShivdasaniRAMcMahonAP. Hedgehog signaling controls mesenchymal growth in the developing mammalian digestive tract. Development2010; 137: 1721–9.
96.
ChaoWOlsonMS. Platelet-activating factor: receptors and signal transduction. Biochem J1993; 292: 617–29.
PritchardDMPottenCSKorsmeyerSJRobertsSHickmanJA. Damage-induced apoptosis in intestinal epithelia from bcl-2-null and bax-null mice: investigations of the mechanistic determinants of epithelial apoptosis in vivo. Oncogene1999; 18: 7287–93.
99.
Kelsall B, Strober W. Gut-associated lymphoid tissue: antigen handling and T-lymphocyte responses. In: Orgra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (eds). Mucosal immunology. 2nd edn. San Diego, CA: Academic Press, 1999, pp. 293–317.
100.
TanakaHMiyamotoKMoritaKHagaHSegawaHShiragaTFujiokaAKoudaTTaketaniYHisanoSFukuiYKitagawaKTakedaE. Regulation of the PepT1 peptide transporter in the rat small intestine in response to 5-fluorouracil-induced injury. Gastroenterology1998; 114: 714–23.
101.
KucukCOzkanMAkgunHMuhtarogluSSozuerE. The effect of granulocyte macrophage-colony stimulating factor on bacterial translocation after administration of 5-fluorouracil in rats. J Surg Res2005; 128: 15–20.
102.
BuermeyerABDeschenesSMBakerSMLiskayRM. Mammalian DNA mismatch repair. Annu Rev Genet1999; 33: 533–64.
103.
PritchardDMPottenCSHickmanJA. The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res1998; 58: 5453–65.
104.
GrossAMcDonnellJMKorsmeyerSJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev1999; 13: 1899–911.
105.
SansomOJZabkiewiczJBishopSMGuyJBirdAClarkeAR. MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine. Oncogene2003; 22: 7130–6.
106.
LiJKudskKAGocinskiBDentDGlezerJLangkamphenkenB. Effects of parenteral and enteral nutrition on gut-associated lymphoid tissue. J Trauma-Injury Inf Crit Care1995; 39: 44–52.
107.
MerrittAJPottenCSKempCJHickmanJABalmainALaneDPHallPA. The role of P53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and P53-deficient mice. Cancer Res1994; 54: 614–17.
108.
NagayoshiHFukatsuKUenoCHaraEMaeshimaYOmataJHiraideHMochizukiH. 5-fluorouracil infusion reduces gut-associated lymphoid tissue cell number and mucosal immunoglobulin A levels. J Parenter Enter Nutr2005; 29: 395–400.
109.
IjiriKPottenC. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer1983; 47: 175–85.
110.
IjiriKPottenC. Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer1987; 55: 113–23.
111.
PottenCS. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev1992; 11: 179–95.
112.
PritchardDMJackmanAPottenCSHickmanJA. Chemically-induced apoptosis: p21 and p53 as determinants of enterotoxin activity. Toxicol Lett1998; 103: 19–27.
113.
PritchardDMWatsonAJPottenCSJackmanALHickmanJA. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc Natl Acad Sci1997; 94: 1795–9.
114.
InomataAHoriiISuzukiK. 5-Fluorouracil-induced intestinal toxicity: what determines the severity of damage to murine intestinal crypt epithelia?Toxicol Lett2002; 133: 231–40.
115.
FishelR. Signaling mismatch repair in cancer. Nat Med1999; 5: 1239–41.
116.
SandovskylosicaHSegalE. Interaction of Candida albicans with murine gastrointestinal mucosa from methotrexate and 5-fluorouracil treated animals: in vitro adhesion and prevention. J Med Vet Mycol1990; 28: 279–87.
117.
MorvanFOBaroukhBLedouxDCaruelleJPBarritaultDGodeauGSaffarJL. An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters. Am J Pathol2004; 164: 739–46.
118.
HirataKHorieT. Changes in intestinal absorption of 5-fluorouracil-treated rats. Pharmacol Toxicol1999; 85: 33–6.
119.
LeeWSKanaiYWellsRGHedigerMA. The high-affinity Na+/glucose cotransporter. Reevaluation of function and distribution of expression. J Biol Chem1994; 269: 12032–9.
120.
TomimatsuTHorieT. Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil. Chem-Biol Interact2005; 155: 129–39.
121.
Van KampenCGauldieJCollinsSM. Proinflammatory properties of IL-4 in the intestinal microenvironment. Am J Physiol-Gastrointest Liver Physiol2005; 288: G111–17.
122.
VermeireSVan AsscheGRutgeertsP. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis2004; 10: 661–5.
123.
JinXLZimmersTAZhangZXPierceRHKoniarisLG. Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut2010; 59: 186–96.
124.
SunXMHsuehW. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest1988; 81: 1328–31.
125.
BormanRAJewellRHillierK. Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro. Br J Pharmacol1998; 123: 231–6.
126.
VenkateshaRTAhamedJNueschCZaidiAKAliH. Platelet-activating factor-induced chemokine gene expression requires NF-kappa B activation and Ca2+/calcineurin signaling pathways - Inhibition by receptor phosphorylation and beta-arrestin recruitment. J Biol Chem2004; 279: 44606–12.
127.
SoaresPMGLimaRCPMotaJJustinoPFCBritoGACRibeiroRACunhaFQSouzaM. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemother Pharmacol2011; 68: 713–20.
128.
LiuSXLTianRLBaskindHHsuehWDe PlaenIG. Platelet-activating factor induces the processing of nuclear factor-kappa B p105 into p50, which mediates acute bowel injury in mice. Am J Physiol-Gastrointest Liver Physiol2009; 297: G76–81.
129.
YonekawaHMurataEAkitaMSatomiA. Reorganized small intestine from fetal mouse as an in vitro wound healing model. J Gastroenterol2003; 38: 442–50.
LiangRMorrisPChoSSCAbudHEJinXQChengW. Hedgehog signaling displays a biphasic expression pattern during intestinal injury and repair. J Pediatr Surg2012; 47: 2251–63.
132.
KangDHHanMESongMHLeeYSKimEHKimHJKimGHKimDHYoonSBaekSYKimBSKimJBOhSO. The role of hedgehog signaling during gastric regeneration. J Gastroenterol2009; 44: 372–9.
133.
AlimontiAGelibterAPaveseISattaFCognettiFFerrettiGRasioDVecchioneADi PalmaM. New approaches to prevent intestinal toxicity of irinotecan-based regimens. Cancer Treat Rev2004; 30: 555–62.
134.
FittkauMVoigtWHolzhausenHJSchmollHJ. Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats. J Cancer Res Clin Oncol2004; 130: 388–94.
135.
YamamotoMKuritaAAsaharaTTakakuraAKatonoKIwasakiMRyugeSWadaMOnodaSYanaiharaTYokobaMMitsufujiHNishjiYFukuiTMasudaN. Metabolism of irinotecan and its active metabolite SN-38 by intestinal microflora in rats. Oncol Rep2008; 20: 727–30.
136.
TrylandIFiksdalL. Enzyme characteristics of beta-D-galactosidase- and beta-D-glucuronidase-positive bacteria and their interference in rapid methods for detection of waterborne coliforms and Escherichia coli. Appl Environ Microbiol1998; 64: 1018–23.
137.
CaoSSBlackJDTrouttABRustumYM. Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model. Cancer Res1998; 58: 3270–4.
138.
LoganRMGibsonRJBowenJMStringerAMSonisSTKeefeDMK. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol2008; 62: 33–41.
139.
LoganRMStringerAMBowenJMGibsonRJSonisSTKeefeDMK. Serum levels of NF kappa B and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther2008; 7: 1139–45.
140.
Al-DasooqiNBowenJMGibsonRJLoganRMStringerAMKeefeDM. Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the dark agouti rat. Int J Exp Pathol2011; 92: 357–65.
141.
BowenJMTsykinAStringerAMLoganRMGibsonRJKeefeDMK. Kinetics and regional specificity of irinotecan-induced gene expression in the gastrointestinal tract. Toxicology2010; 269: 1–12.
142.
BowenJMGibsonRJStringerAMChanTWPrabowoASCumminsAGKeefeDMK. Role of p53 in irinotecan-induced intestinal cell death and mucosal damage. Anti-Cancer Drug2007; 18: 197–210.
143.
Al-DasooqiNGibsonRJBowenJMLoganRMStringerAMKeefeDM. Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat. Exp Biol Med2010; 235: 1244–56.
144.
ManiconeAMMcGuireJK. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol2008; 19: 34–41.
145.
WolfMAlbrechtSMarkiC. Proteolytic processing of chemokines: Implications in physiological and pathological conditions. Int J Biochem Cell Biol2008; 40: 1185–98.
146.
StringerAMGibsonRJLoganRMBowenJMYeohASJLaurenceJKeefeDMK. Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemother Pharmacol2009; 64: 123–32.
147.
StringerAMGibsonRJLoganRMBowenJMYeohASJKeefeDMK. Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. Cancer Biol Ther2008; 7: 1919–25.
148.
NakaoTKuritaNKomatsuMYoshikawaKIwataTUtusnomiyaTShimadaM. Irinotecan injures tight junction and causes bacterial translocation in rat. J Surg Res2012; 173: 341–7.
149.
BrandiGDabardJRaibaudPDi BattistaMBridonneauCPisiAMLabateAMMPantaleoMADe VivoABiascoG. Intestinal microflora and digestive toxicity of irinotecan in mice. Clin Cancer Res2006; 12: 1299–307.
150.
DruckerDJEhrlichPAsaSLBrubakerPL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A1996; 93: 7911–16.
151.
LeeSJLeeJLiKKHollandDMaughanHGuttmanDSYustaBDruckerDJ. Disruption of the murine Glp2r impairs paneth cell function and increases susceptibility to small bowel enteritis. Endocrinology2012; 153: 1141–51.
